Filing Details
- Accession Number:
- 0001131399-10-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-04 12:00:00
- Reporting Period:
- 2009-12-30
- Filing Date:
- 2010-01-04
- Accepted Time:
- 2010-01-04 13:50:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1068796 | Maxygen Inc | MAXY | Services-Commercial Physical & Biological Research (8731) | 770449487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1131399 | Plc Glaxosmithkline | 980 Great West Road Brentford Middlesex X0 TW8 9GS | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Par Value $0.0001 Per Share | Disposition | 2009-12-30 | 5,121,488 | $5.30 | 1,433,361 | No | 4 | S | Indirect | By Corporation |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Corporation |
Footnotes
- All shares covered by this report are beneficially owned by direct or indirect wholly-owned subsidiaries of Reporting Person. The Reporting Person may be deemed, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Act") to be the beneficial owner of Glaxo Group Limited and GlaxoSmithKline Services Unlimited and, therefore, may be deemed to be a "10 per cent beneficial owner" for the purposes of Section 16 of the Act.
Billionaire Hedge Funds
